# FDA Inspection 1240371 - Takeda Ireland Ltd - July 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/takeda-ireland-ltd/c8837b00-aa2d-4298-a28c-b22df154b265
Source feed: FDA_Inspections

> FDA Inspection 1240371 for Takeda Ireland Ltd on July 14, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1240371
- Company Name: Takeda Ireland Ltd
- Inspection Date: 2023-07-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 972381 - 2016-05-26](https://www.keypedia.com/records/fda_inspections/takeda-ireland-ltd/05957f7a-5d98-45e7-b978-872303787504)
- [FDA Inspection 839990 - 2013-06-20](https://www.keypedia.com/records/fda_inspections/takeda-ireland-ltd/7964238b-80b9-44b6-ab31-620a3edcae71)

Company: https://www.keypedia.com/companies/takeda-ireland-ltd/88620821-e6b8-454b-ac4f-4729be466d67

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c